GlassScriptPhysician profile
Marc A Adajar
NPI 1508947383
$7,566.62
in general payments reported to CMS, 2019-2025
17 companies · $1,212 in 2025
The $1,212 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,033 · 2020: $1,827 · 2022: $930 · 2023: $390 · 2024: $1,175 · 2025: $1,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,775.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $3,711.84 | 2019-2024 | Tisseel |
| Acera Surgical, INC. | $957.95 | 2024-2025 | Restrata Wound Matrix |
| Covidien LP | $950.00 | 2019 | |
| Kerecis Limited | $300.55 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Tela Bio, INC. | $287.43 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Endogastric Solutions, INC | $264.10 | 2019-2023 | Esophyx |
| Integra Lifesciences Corporation | $159.16 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Shockwave Medical, INC | $139.29 | 2025 | |
| Aroa Biosurgery Incorporated | $133.52 | 2025 | |
| Davol INC. | $121.88 | 2025 | Arista |
| Phathom Pharmaceuticals, INC. | $120.80 | 2024 | Voquezna |
| Innovation Technologies INC | $108.14 | 2024 | Irrisept |
| Thd America, INC. | $99.58 | 2025 | |
| Solventum Corporation | $87.43 | 2024 | V.A.C. Veraflo, Abthera, Prevena |
| Smith+Nephew, INC. | $83.34 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $25.90 | 2019 | |
| Coopersurgical, INC. | $15.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Adajar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.